Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Lupin    LUPIN   INE326A01037

LUPIN (LUPIN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

LUPIN : GETS UK REGULATOR NOD FOR GOA FACILITY

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/17/2018 | 10:46am CEST

Pharmaceutical firm Lupin Limited has announced the receipt of approval from Medicines and Healthcare Products Regulatory Agency of UK for its Goa facility. The facility was inspected by the regulatory authority in Mar 2018 and there were no major or critical observations.

Copyright (c) 2018 . Informatics India Ltd., source Indian Business Insight

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LUPIN
07/17LUPIN : Gets uk regulator nod for goa facility
AQ
07/17LUPIN : Gets uk nod for goa facility
AQ
07/16LUPIN : receives FDA approval for generic Nitrofurantoin Capsules USP, 50 mg and..
AQ
07/13LUPIN : receives FDA approval for generic Hydroxychloroquine Sulfate Tablets USP..
AQ
07/12Exclusive - With U.S. trade under a cloud, China opens to Indian pharma
RE
07/03LUPIN : and Mylan Partner to Commercialize Enbrel Biosimilar
AQ
07/01LUPIN : Looks to ride japan's biosimilars wave
AQ
06/30LUPIN : Launches anti-tb campaign in mumbai
AQ
06/29LUPIN : teams up with Mylan to sell arthritis drug
AQ
06/29LUPIN : Trailing twelve month results - lupin limited
AQ
More news
Financials (INR)
Sales 2019 169 B
EBIT 2019 22 483 M
Net income 2019 15 879 M
Debt 2019 37 963 M
Yield 2019 0,79%
P/E ratio 2019 23,31
P/E ratio 2020 18,98
EV / Sales 2019 2,44x
EV / Sales 2020 2,15x
Capitalization 374 B
Chart LUPIN
Duration : Period :
Lupin Technical Analysis Chart | LUPIN | INE326A01037 | 4-Traders
Technical analysis trends LUPIN
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 40
Average target price 837  INR
Spread / Average Target 1,2%
EPS Revisions
Managers
NameTitle
Nilesh Deshbandhu Gupta Managing Director & Executive Director
Vinita D. Gupta Chief Executive Officer & Executive Director
Manju Deshbandhu Gupta Chairman
Ramesh Swaminathan Chief Financial Officer & Executive Director
Alok Ghosh President-Technical Operations
Sector and Competitors
1st jan.Capitalization (M$)
LUPIN-6.66%5 459
JOHNSON & JOHNSON-10.76%346 292
PFIZER3.20%220 236
ROCHE HOLDING LTD.-5.88%200 995
NOVARTIS-5.10%200 139
MERCK AND COMPANY11.12%168 225